Simbarashe Takuva
7PUBLICATIONS
41CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Mar 19, 2024
Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial.Zoe Moodie, Erica Andersen-Nissen, Nicole Grunenberg
|Jun 21, 2022
Safety evaluation of the single-dose Ad26.COV2.S vaccine among healthcare workers in the Sisonke study in South Africa: A phase 3b implementation trial.Simbarashe Takuva, Azwidhwi Takalani, Ishen Seocharan
|Jul 07, 2021
Incidence of cardiometabolic diseases in a Lesotho HIV cohort: Evidence for policy decision-making.Motlalepula Sebilo, Neo R T Ledibane, Simbarashe Takuva
|Jun 02, 2021
Thromboembolic Events in the South African Ad26.COV2.S Vaccine Study.Simbarashe Takuva, Azwidhwi Takalani, Nigel Garrett
|Mar 24, 2021
Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120-MF59 in Adults.Glenda E Gray, Linda-Gail Bekker, Fatima Laher
|Mar 17, 2021
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition.Lawrence Corey, Peter B Gilbert, Michal Juraska
Pageof 2
Frequent Collaborators
3 joint publications
Lawrence Corey
3 joint publications
Glenda Gray
2 joint publications
Olivier Van Der Meeren
2 joint publications
Vernon Louw
1 joint publications
Tendesayi Kufa
1 joint publications
William MacLeod
1 joint publications
Jeffrey W Eaton
1 joint publications
Nicole Fraser-Hurt
1 joint publications
Nima S Hejazi
1 joint publications
Motlalepula Sebilo
